AdvaMed will establish an office in China before the close of the year, a move that will highlight the long-term commitment of the U.S. medtech industry to the Chinese market, AdvaMed President and CEO Stephen Ubl said. As part of the effort, the group has appointed Lynn Jiao as executive director of its China Program.

Related Summaries